| Low sensitivity of BinaxNOW RSV in infants RP Zuurbier, LJ Bont, AC Langedijk, M Hamer, K Korsten, SB Drysdale, ... The Journal of infectious diseases 222 (Supplement_7), S640-S647, 2020 | 8 | 2020 |
| A systematic review of clinical practice guidelines for the diagnosis and management of bronchiolitis A Kirolos, S Manti, R Blacow, G Tse, T Wilson, M Lister, S Cunningham, ... The Journal of infectious diseases 222 (Supplement_7), S672-S679, 2020 | 109 | 2020 |
| First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on chimpanzee-adenovirus-155 viral … P Cicconi, C Jones, E Sarkar, L Silva-Reyes, P Klenerman, C de Lara, ... Clinical Infectious Diseases 70 (10), 2073-2081, 2020 | 51 | 2020 |
| Safety profile of the RTS, S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa Y Guerra Mendoza, E Garric, A Leach, M Lievens, O Ofori-Anyinam, ... Human vaccines & immunotherapeutics 15 (10), 2386-2398, 2019 | 64 | 2019 |
| 2855. Respiratory Syncytial Virus Neutralizing Antibodies in Cord Blood and Serum from Infants up to 2 Years of Age in a Multinational Prospective Study JB Domachowske, V Bianco, A Ceballos, L Cousin, U D’Andrea, ... Open Forum Infectious Diseases 6 (Supplement_2), S74-S75, 2019 | | 2019 |
| Immune response to the hepatitis B antigen in the RTS, S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: a … I Valéa, S Adjei, E Usuf, O Traore, D Ansong, H Tinto, H Owusu Boateng, ... Human vaccines & immunotherapeutics 14 (6), 1489-1500, 2018 | 16 | 2018 |
| Safety and immunogenicity of seven dosing regimens of the candidate RTS, S/AS01E malaria vaccine integrated within an expanded program on immunization regimen: a phase II … D Witte, NA Cunliffe, AM Turner, E Ngulube, O Ofori-Anyinam, ... The Pediatric Infectious Disease Journal 37 (5), 483-491, 2018 | 12 | 2018 |
| Safety and immunogenicity of RTS, S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial L Otieno, M Oneko, W Otieno, J Abuodha, E Owino, C Odero, ... The Lancet Infectious Diseases 16 (10), 1134-1144, 2016 | 39 | 2016 |
| Seven-year efficacy of RTS, S/AS01 malaria vaccine among young African children A Olotu, G Fegan, J Wambua, G Nyangweso, A Leach, M Lievens, ... New England Journal of Medicine 374 (26), 2519-2529, 2016 | 470 | 2016 |
| Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ... New England Journal of Medicine 373 (21), 2025-2037, 2015 | 435 | 2015 |
| PARASITE GENETIC DIVERSITY AND PROTECTIVE EFFICACY IN A PHASE 3 TRIAL OF THE RTS, S/AS01 MALARIA VACCINE DE Neafsey, M Juraska, T Bedford, DC Benkeser, C Valim, AD Griggs, ... AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 93 (4), 112-112, 2015 | | 2015 |
| Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine H Tinto, PG Kremsner, D Lapierre, D Ansong, Q Yu, SK Volkman, ... The New England Journal of Medicine, 2015 | 1 | 2015 |
| Immunogenicity and safety of the candidate RTS, S/AS01 vaccine in young Nigerian children: A randomized, double-blind, lot-to-lot consistency trial R Umeh, S Oguche, T Oguonu, S Pitmang, E Shu, JT Onyia, CA Daniyam, ... Vaccine 32 (48), 6556-6562, 2014 | 12 | 2014 |
| Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02D malaria vaccine in infants living in a malaria-endemic region S Abdulla, N Salim, F Machera, R Kamata, O Juma, M Shomari, ... Malaria journal 12, 1-11, 2013 | 67 | 2013 |
| Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure A Olotu, G Fegan, J Wambua, G Nyangweso, KO Awuondo, A Leach, ... New England Journal of Medicine 368 (12), 1111-1120, 2013 | 359 | 2013 |
| Vaccine impact on carriage and lower airway infection in Australian Indigenous children with bronchiectasis K Hare, H Smith-Vaughan, A Leach, A Chang Respirology 18 (Supp. s2), 83-83, 2013 | | 2013 |
| Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS, S/AS01 malaria vaccine A Horowitz, JCR Hafalla, E King, J Lusingu, D Dekker, A Leach, P Moris, ... The Journal of Immunology 188 (10), 5054-5062, 2012 | 92 | 2012 |
| Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care J Vekemans, K Marsh, B Greenwood, A Leach, W Kabore, ... Malaria journal 10, 1-13, 2011 | 41 | 2011 |
| Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa A Leach, J Vekemans, M Lievens, O Ofori-Anyinam, C Cahill, ... Malaria journal 10, 1-13, 2011 | 90 | 2011 |
| Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children M Lievens, JJ Aponte, J Williamson, B Mmbando, A Mohamed, P Bejon, ... Malaria journal 10, 1-8, 2011 | 37 | 2011 |
